The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

ECyd     4-amino-1-[(2R,3S,4S,5R)-4- ethynyl-3,4...

Synonyms: ETHYNYCYTIDINE, TAS-106, CHEMBL573352, NSC722662, PB24694, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of TAS-106

 

High impact information on TAS-106

 

Biological context of TAS-106

 

Anatomical context of TAS-106

  • Measurement of UCK activity in these cell lines revealed that it was well correlated with the cells' sensitivity to TAS-106 [5].
 

Gene context of TAS-106

 

Analytical, diagnostic and therapeutic context of TAS-106

  • The antitumor ribonucleoside analogues 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd) and 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil (EUrd), first synthesized in 1995, have strong antitumor activity against human cancer xenografts without severe side effects [7].
  • During the development of the liquid chromatography with electrospray ionization-tandem mass spectrometry for the quantitative determination of 3'-C-ethynylcytidine (I) in rat plasma, ion suppression caused by the matrix components was observed for I and its structural analogue, 3'-C-ethylcytidine (II) as the internal standard [8].

References

  1. Cellular and biochemical mechanisms of the resistance of human cancer cells to a new anticancer ribo-nucleoside, TAS-106. Shimamoto, Y., Kazuno, H., Murakami, Y., Azuma, A., Koizumi, K., Matsuda, A., Sasaki, T., Fukushima, M. Jpn. J. Cancer Res. (2002) [Pubmed]
  2. Antitumor activity and pharmacokinetics of TAS-106, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine. Shimamoto, Y., Fujioka, A., Kazuno, H., Murakami, Y., Ohshimo, H., Kato, T., Matsuda, A., Sasaki, T., Fukushima, M. Jpn. J. Cancer Res. (2001) [Pubmed]
  3. Possible antitumor activity of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106) against an established gemcitabine (dFdCyd)-resistant human pancreatic cancer cell line. Kazuno, H., Sakamoto, K., Fujioka, A., Fukushima, M., Matsuda, A., Sasaki, T. Cancer Sci. (2005) [Pubmed]
  4. X irradiation induces the proapoptotic state independent of the loss of clonogenic ability in Chinese hamster V79 cells. Iizuka, D., Inanami, O., Matsuda, A., Kashiwakura, I., Asanuma, T., Kuwabara, M. Radiat. Res. (2005) [Pubmed]
  5. Sensitivity of human cancer cells to the new anticancer ribo-nucleoside TAS-106 is correlated with expression of uridine-cytidine kinase 2. Shimamoto, Y., Koizumi, K., Okabe, H., Kazuno, H., Murakami, Y., Nakagawa, F., Matsuda, A., Sasaki, T., Fukushima, M. Jpn. J. Cancer Res. (2002) [Pubmed]
  6. A novel anticancer ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine, enhances radiation-induced cell death in tumor cells. Inanami, O., Iizuka, D., Iwahara, A., Yamamori, T., Kon, Y., Asanuma, T., Matsuda, A., Kashiwakura, I., Kitazato, K., Kuwabara, M. Radiat. Res. (2004) [Pubmed]
  7. Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil. Takatori, S., Kanda, H., Takenaka, K., Wataya, Y., Matsuda, A., Fukushima, M., Shimamoto, Y., Tanaka, M., Sasaki, T. Cancer Chemother. Pharmacol. (1999) [Pubmed]
  8. Improvement in precision of the liquid chromatographic-electrospray ionization tandem mass spectrometric analysis of 3'-C-ethynylcytidine in rat plasma. Kitamura, R., Matsuoka, K., Matsushima, E., Kawaguchi, Y. J. Chromatogr. B Biomed. Sci. Appl. (2001) [Pubmed]
 
WikiGenes - Universities